Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 9 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 11285153

    Substituted pyrimidine piperazine compound and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  2. US 11266488

    Tissue repair fiber membrane, preparation method and application thereof, and tissue repair product

    Medprin Regenerative Medical Technologies Co., Ltd. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  3. US 11261190

    Dihydropyrimidine compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  4. US 11261230

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  5. US 11254746

    Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  6. US 11253604

    Conjugate of methotrexate and peptide

    CAREGEN CO., LTD. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  7. US 11242335

    Fluorine-substituted indazole compounds and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  8. US 11225477

    Inhibitors of influenza virus replication, application methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  9. US 11224630

    Medicinal composition for protection of joints, method for producing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  10. US 11225460

    Pyrrolidineamide derivatives and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  11. US 11225648

    Modified DNase and uses thereof

    Protalix Ltd. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  12. US 11213529

    Salt of substituted urea derivative and use thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted
  13. US 11208418

    Nitrogenous tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  14. US 11207333

    Compositions comprising triterpenoids and uses thereof for treating optic neuropathy

    REGENERA PHARMA LTD. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  15. US 11197907

    Antimicrobial compounds from the genus Delftia

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  16. US 11191843

    Multi-arm targeting anti-cancer conjugate

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  17. US 11191761

    SOMCL-9112 solid dispersion and preparation method thereof and SOMCL-9112 solid preparation containing SOMCL-9112 solid dispersion

    Shanghai Acebright Pharmaceuticals Group Co., Ltd. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  18. US 11186873

    Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

    Wellmarker Bio Co., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  19. US 11185572

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  20. US 11186602

    Glucopyranosyl derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  21. US 11186611

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  22. US 11179486

    Wet wiper

    KURARAY KURAFLEX CO., LTD. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  23. US 11179376

    Salts of pyrazolo[1,5-a]pyridine derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  24. US 11179467

    Exenatide modifier and use thereof

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted